Do you want to read an article? Please log in or register.
Longer-term open-label study of adjunctive riluzole in treatment-resistant depression
Anxiety and Depression
Related content
Anxiety and Depression
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)
J Clin Psychiatry.
Wajs E, Aluisio L, Holder R, Daly EJ, Lane R, Lim P, George JE, Morrison RL, Sanacora G, Young AH, Kasper S, Sulaiman AH, Li CT, Paik JW, Manji H, Hough D, Grunfeld J, Jeon HJ, Wilkinson ST, Drevets WC, Singh JB
doi: 10.4088/JCP.19m12891.
Further Publications Psychiatry
Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study
J Affect Disord
Ishigooka J, Kato T, Miyajima M, Watabe K, Masuda T, Hagi K, Higuchi T
doi: 10.1016/j.jad.2020.12.005
Further Publications NeurologyFurther Publications Psychiatry
Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial
Lancet Psychiatry.
Marsden J, Stillwell G, James K, Shearer J, Byford S, Hellier J, Kelleher M, Kelly J, Murphy C, Mitcheson L
doi: 10.1016/S2215-0366(19)30097-5.
Anxiety and Depression
A meta-analysis of the potential antidepressant effects of buprenorphine versus placebo as an adjunctive pharmacotherapy for treatment-resistant depression
J Affect Disord.
Dinoff A, Lynch ST, Sekhri N, Klepacz L
doi: 10.1016/j.jad.2020.03.089.
Epilepsy
Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies
Epilepsia.
Rektor I, Krauss GL, Inoue Y, Kaneko S, Williams B, Patten A, Malhotra M, Laurenza A, Wechsler RT
doi: 10.1111/epi.16573.
Anxiety and Depression
Psychological therapies for treatment-resistant depression in adults
Cochrane Database Syst Rev.
Ijaz S, Davies P, Williams CJ, Kessler D, Lewis G, Wiles N
doi: 10.1002/
Anxiety and Depression
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples
Br J Psychiatry.
Fabbri C, Kasper S, Kautzky A, Bartova L, Dold M, Zohar J, Souery D, Montgomery S, Albani D, Raimondi I, Dikeos D, Rujescu D, Uher R, Lewis CM, Mendlewicz J, Serretti A
doi: 10.1192/bjp.2018.256.
RECOMMENDED
Migraine and Headache
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)
Cephalalgia.
Brandes JL, Klise S, Krege JH, Case M, Khanna R, Vasudeva R, Raskin J, Pearlman EM, Kudrow D
doi: 10.1177/0333102419864132.
Epilepsy
Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Epilepsia.
O'Brien TJ, Borghs S, He QJ, Schulz AL, Yates S, Biton V
doi: 10.1111/epi.16484.